/ /

CLINICAL

3 tips to better fit keratocones with sclerals
3 tips to better fit keratocones with scleralsYou may have heard success stories with patients fit in scleral lenses and seen discussion in literature regarding the finer points of fitting these contact lenses. If you are not currently fitting scleral contact lenses but are interested in working with them, we recommend three things to prepare yourself and your practice to fit scleral lenses.
Understanding the conundrum of conjunctivochalasisConjunctival chalasis, or conjunctivochalasis (Cch), is a commonly observed condition in our everyday patient care experiences. Because it is so common, and because a majority of patients are asymptomatic, optometrists seldom feel the need treat.
Applying hydrogel technology to sustained-release ocular drugsHydrogel technology enables the use of drugs that are known to be efficacious for ocular diseases and conditions when formulated as daily drops or monthly injections, into one-time or several-month dosage forms.
How vaping affects the ocular surfaceElectronic cigarettes (e-cigarettes) are devices designed to deliver nicotine in a solution rather than smoke without tobacco combustion. Perceived by consumers as a safer alternative to conventional cigarettes, e-cigarettes are aggressively marketed as lifestyle-choice consumables.
New eye drop assistant helps drive complianceAs ODs, we are fully aware of the challenge patient compliance with prescribed eye drops. To assuage the battle of compliance, eye drop manufacturers are assiduously working to devise drug delivery systems that reduce or eliminate patients’ engagement in the instillation of their prescribed therapy. But until ODs no longer use eye drops, drops remain our primary mode of drug delivery.
The changing dry eye dynamicTo understand how far we have come, you must remember where we started.
Glasses and contact lenses: Have they become a commodity?Sell the best thing you have going for you—you.
Aflibercept helps in ME patients with DR after cataract surgeryPatients with diabetic retinopathy have a high risk of developing macular edema after cataract surgery. Intravitreal injections of aflibercept might result in fewer patients developing macular edema in this patient population.
ALG-1001: Turning off the machinery of angiogenesisALG-1001 (Luminate, Allegro Ophthalmics) has a number of different mechanisms of action that benefit patients chronically treated with anti-vascular endothelial growth factor drugs and those who are treatment naïve.
AO imaging offers novel data for understanding retinal diseaseAdaptive optics (AO) is providing new insights about retinal structure and may help to identify potential areas for treatment of retinal diseases, said Mina Chung, MD.